CAPR - Capricor gains FDA pre-BLA meeting on deramiocel for Duchenne muscular dystrophy
2024-06-25 09:30:36 ET
More on Capricor Therapeutics
- Capricor: Rolling BLA Submission Of CAP-1002 To Get DMD Treatment Program Going
- Capricor Therapeutics, Inc. (CAPR) Q1 2024 Earnings Call Transcript
- Capricor Therapeutics stock rises, Oppenheimer initiates coverage at Outperform
- Capricor Therapeutics Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Capricor Therapeutics